Lv7
3710 积分 2022-09-20 加入
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma
2个月前
已完结
Hepatocellular Carcinoma
2个月前
已完结
Targeting the tumour vasculature: from vessel destruction to promotion
2个月前
已完结
COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
2个月前
已完结
Targeted MSC therapy restores implantation by spatially reconstituting the RSPO1 niche via IL10-CXCL12 signaling
3个月前
已关闭
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
3个月前
已完结
Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment
3个月前
已完结
Cancer-associated fibroblasts regulating nanomedicine to overcome sorafenib resistance in hepatocellular carcinoma with portal vein tumor thrombus
3个月前
已完结
The immunological and metabolic landscape in primary and metastatic liver cancer
3个月前
已完结
Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment
3个月前
已完结
皖公网安备34019202002308
